These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34545504)

  • 1. Outcomes of retesting in patients with previously uninformative cancer genetics evaluations.
    Dettwyler SA; Koeppe ES; Jacobs MF; Stoffel EM
    Fam Cancer; 2022 Jul; 21(3):375-385. PubMed ID: 34545504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients.
    Isiklar AD; Aliyeva L; Yesilyurt A; Soyder A; Basaran G
    Breast Cancer Res Treat; 2023 Nov; 202(2):297-304. PubMed ID: 37615792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
    Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
    Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy.
    Dettwyler SA; Thull DL; McAuliffe PF; Steiman JG; Johnson RR; Diego EJ; Mai PL
    Breast Cancer Res Treat; 2022 Jul; 194(2):393-401. PubMed ID: 35596825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.
    Ni M; Wang F; Yang A; Shao Q; Xue C; Xia W; Xu F; Lin X; Huang J; Bi X; Hong R; Chen M; Zheng Q; Jiang K; Xie X; Tang J; Wang X; Yuan Z; Wang S; Shi Y; An X
    Cancer Med; 2023 Jun; 12(12):13019-13030. PubMed ID: 37096751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results from London Regional Clinical Genetics services over a 5-year period on germline
    Garrett A; Talukdar S; Izatt L; Brady AF; Whyte S; Josephs KS; Shanmugasundaram M; Guillemot LS; Vakili D; Ey S; Ahmed M
    J Med Genet; 2022 Jun; 59(6):554-558. PubMed ID: 34266904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
    Sabol RA; Ledet EM; Jaeger E; Hatton W; Moses M; Lankford A; Zaheria A; Barata P; Layton JL; Lewis BE; Sartor O
    Prostate; 2021 May; 81(7):427-432. PubMed ID: 33760238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration.
    Karloski E; Dudley B; Diergaarde B; Blanco A; Everett JN; Levinson E; Rangarajan T; Stanich PP; Childers K; Brown S; Drogan C; Cavestro GM; Gordon K; Singh A; Simeone DM; Reich H; Kastrinos F; Zakalik D; Hampel H; Pearlman R; Gordon OK; Kupfer SS; Puzzono M; Zuppardo RA; Brand RE
    Cancer; 2024 Oct; 130(19):3297-3304. PubMed ID: 38809542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral Disease Common Among Slovenian CHEK2-Positive Breast Cancer Patients.
    Nizic-Kos T; Krajc M; Blatnik A; Stegel V; Skerl P; Novakovic S; Gazic B; Besic N
    Ann Surg Oncol; 2021 May; 28(5):2561-2570. PubMed ID: 33030641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
    Ledet EM; Burgess EF; Sokolova AO; Jaeger EB; Hatton W; Moses M; Miller P; Cotogno P; Layton J; Barata P; Lewis BE; Nakazawa M; Zhu J; Dellinger B; Elrefai S; Nafissi NN; Egan JB; Shore N; McKay RR; Bryce AH; Cheng HH; Antonarakis ES; Sartor O
    Prostate; 2021 May; 81(7):433-439. PubMed ID: 33792945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and frequency of CHEK2 variants in breast cancer affected and general population in the Baltic states region, initial results and literature review.
    Pavlovica K; Irmejs A; Noukas M; Palover M; Kals M; Tonisson N; Metspalu A; Gronwald J; Lubinski J; Murmane D; Kalnina A; Loza P; Maksimenko J; Trofimovics G; Subatniece S; Daneberga Z; Miklasevics E; Gardovskis J
    Eur J Med Genet; 2022 May; 65(5):104477. PubMed ID: 35314380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of targeted cascade genetic testing in the family members of BRCA1/2 gene pathogenic variant/likely pathogenic variant carriers.
    Lee J; Ham JY; Park HY; Jung JH; Kim WW; Kang B; Chae YS; Lee SJ; Lee IH; Lee NY
    Sci Rep; 2022 Feb; 12(1):1842. PubMed ID: 35115620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of retesting BRCA negative patients using multigene panels.
    Yadav S; Reeves A; Campian S; Paine A; Zakalik D
    Fam Cancer; 2017 Jul; 16(3):319-328. PubMed ID: 27878467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients.
    Siraj AK; Bu R; Parvathareddy SK; Iqbal K; Azam S; Qadri Z; Al-Rasheed M; Haqawi W; Diaz M; Victoria IG; Al-Badawi IA; Tulbah A; Al-Dayel F; Ajarim D; Al-Kuraya KS
    Sci Rep; 2023 May; 13(1):7666. PubMed ID: 37169825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.
    Al Saati A; Vande Perre P; Plenecassagnes J; Gilhodes J; Monselet N; Cabarrou B; Lignon N; Filleron T; Telly D; Perello-Lestrade E; Feillel V; Staub A; Martinez M; Chipoulet E; Collet G; Thomas F; Gladieff L; Toulas C
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational profile of hereditary breast and ovarian cancer - Establishing genetic testing guidelines in a developing country.
    Krivokuca A; Mihajlovic M; Susnjar S; Spasojevic IB; Minic I; Popovic L; Brankovic-Magic M
    Curr Probl Cancer; 2022 Feb; 46(1):100767. PubMed ID: 34284872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore.
    Zhang Z; Ishak NDB; Que FVF; Chua ZY; Chan SH; Chiang J; Yie JNY
    Hered Cancer Clin Pract; 2023 Apr; 21(1):5. PubMed ID: 37046302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in
    Stegel V; Blatnik A; Škof E; Dragoš VŠ; Krajc M; Gregorič B; Škerl P; Strojnik K; Klančar G; Banjac M; Žgajnar J; Ravnik M; Novaković S
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of mutations in a diverse cohort of 3162 women tested via the same multigene cancer panel in a managed care health plan.
    Alvarado M; Tiller GE; Chung J; Haque R
    J Community Genet; 2020 Jul; 11(3):359-366. PubMed ID: 32096056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.